KNE.V · Kane Biotech Inc.
Canada · RS rating 15 · As of 2026-10-14
| Price | 0.03 CAD |
|---|---|
| 1-day change | -16.7% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 19 / 19 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 12 / 2 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -81.2% |
| Distance from 52-week high | +50.0% |
| Market cap (USD) | $4.3M |